Children will no longer routinely be prescribed puberty blockers at gender identity clinics, NHS England has confirmed.
The decision comes after a review found there was "not enough evidence" they are safe or effective.
Puberty blockers, which pause the physical changes of puberty, will now only be available as part of research.
It comes weeks before an independent review into gender identity services in England is due to be published.
An interim report from the review, published in 2022 by Dr Hilary Cass, had earlier found there were "gaps in evidence" around the drugs and called for a transformation in the model of care for children with gender-related distress.
Health Minister Maria Caulfield said: "We have always been clear that children's safety and wellbeing is paramount, so we welcome this landmark decision by the NHS.
"Ending the routine prescription of puberty blockers will help ensure that care is based on evidence, expert clinical opinion and is in the best interests of the child."
Source: BBC News, 13 March 2024
Recommended Comments
Create an account or sign in to comment